KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) Gross Profit: 2018-2024

Historic Gross Profit for Castle Biosciences (CSTL) over the last 7 years, with Dec 2024 value amounting to $271.9 million.

  • Castle Biosciences' Gross Profit fell 8.31% to $64.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $274.6 million, marking a year-over-year increase of 7.52%. This contributed to the annual value of $271.9 million for FY2024, which is 55.52% up from last year.
  • According to the latest figures from FY2024, Castle Biosciences' Gross Profit is $271.9 million, which was up 55.52% from $174.8 million recorded in FY2023.
  • In the past 5 years, Castle Biosciences' Gross Profit registered a high of $271.9 million during FY2024, and its lowest value of $53.0 million during FY2020.
  • Its 3-year average for Gross Profit is $183.9 million, with a median of $174.8 million in 2023.
  • Data for Castle Biosciences' Gross Profit shows a peak YoY skyrocketed of 66.43% (in 2023) over the last 5 years.
  • Over the past 5 years, Castle Biosciences' Gross Profit (Yearly) stood at $53.0 million in 2020, then surged by 47.77% to $78.3 million in 2021, then spiked by 34.20% to $105.0 million in 2022, then spiked by 66.43% to $174.8 million in 2023, then spiked by 55.52% to $271.9 million in 2024.